Literature DB >> 9231659

Skeletal muscle myosin heavy chain synthesis in type 1 diabetes.

M R Charlton1, P Balagopal, K S Nair.   

Abstract

Although insulin's anticatabolic effect on protein metabolism in type 1 diabetes has been clearly shown to be related to the inhibition of protein breakdown, insulin's effect on muscle protein synthesis remains controversial. Cross-limb studies and measurements of synthesis rates of mixed muscle protein have yielded conflicting results. These measurements represent the mean synthesis of several muscle proteins and may miss changes in the synthesis rates of individual muscle proteins. We measured the fractional synthesis rates of myosin heavy chain (MHC), the principal muscle contractile protein, and mixed muscle protein (MMP) in six type 1 diabetic patients during insulin deprivation and insulin treatment. Comparisons were made with six healthy control subjects. Muscle biopsies were taken at 2 h and 8 h during a primed continuous infusion of L-[1-13C]leucine. MHC was purified by a preparative continuous elution gel electrophoresis, and fractional synthesis rates were calculated. We found that in type 1 diabetic subjects, the fractional synthesis rates of MHC and MMP during insulin treatment are similar to those of control subjects. Acute insulin deprivation did not affect either the synthesis rate or the ratio of MHC to MMP in type 1 diabetic subjects. In the postabsorptive state, acute insulin deprivation has no effect on MHC or MMP synthesis in type 1 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231659     DOI: 10.2337/diab.46.8.1336

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  Release of skeletal muscle peptide fragments identifies individual proteins degraded during insulin deprivation in type 1 diabetic humans and mice.

Authors:  Matthew M Robinson; Surendra Dasari; Helen Karakelides; H Robert Bergen; K Sreekumaran Nair
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-19       Impact factor: 4.310

Review 2.  Role of insulin in the regulation of human skeletal muscle protein synthesis and breakdown: a systematic review and meta-analysis.

Authors:  Haitham Abdulla; Kenneth Smith; Philip J Atherton; Iskandar Idris
Journal:  Diabetologia       Date:  2015-09-24       Impact factor: 10.122

Review 3.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

Review 4.  Human muscle protein turnover--why is it so variable?

Authors:  Gordon I Smith; Bruce W Patterson; Bettina Mittendorfer
Journal:  J Appl Physiol (1985)       Date:  2010-11-25

5.  Influence of insulin and muscle fiber type in nepsilon-(carboxymethyl)-lysine accumulation in soleus muscle of rats with streptozotocin-induced diabetes mellitus.

Authors:  LeAnn M Snow; Ladora V Thompson
Journal:  Pathobiology       Date:  2009-10-02       Impact factor: 4.342

6.  High insulin combined with essential amino acids stimulates skeletal muscle mitochondrial protein synthesis while decreasing insulin sensitivity in healthy humans.

Authors:  Matthew M Robinson; Mattias Soop; Tae Seo Sohn; Dawn M Morse; Jill M Schimke; Katherine A Klaus; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

7.  Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.

Authors:  Matthew P Krause; Jasmin Moradi; Aliyah A Nissar; Michael C Riddell; Thomas J Hawke
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

8.  Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice.

Authors:  Piotr Zabielski; Ian R Lanza; Srinivas Gopala; Carrie J Holtz Heppelmann; H Robert Bergen; Surendra Dasari; K Sreekumaran Nair
Journal:  Diabetes       Date:  2015-12-30       Impact factor: 9.461

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.